Cargando…
Expression of SARS-CoV-2 receptor angiotensin-converting enzyme 2 by activating protein-1 in human mast cells
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection activates mast cells and induces a cytokine storm, leading to severe Coronavirus disease in 2019 (COVID-19). SARS-CoV-2 employs angiotensin-converting enzyme 2 (ACE2) for cell entry. In the present study, the expression of ACE2 a...
Autores principales: | Kim, Hee-Yun, Kang, Ho-Geun, Kim, Hyung-Min, Jeong, Hyun-Ja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985914/ https://www.ncbi.nlm.nih.gov/pubmed/36898276 http://dx.doi.org/10.1016/j.cellimm.2023.104705 |
Ejemplares similares
-
Comparison of SARS-CoV-2 variant lethality in human angiotensin-converting enzyme 2 transgenic mice
por: Lee, Tae-Young, et al.
Publicado: (2021) -
Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2
por: Barker, Harlan, et al.
Publicado: (2020) -
Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
por: Bian, Jingwei, et al.
Publicado: (2021) -
SARS-CoV-2, the Angiotensin Converting Enzyme 2 (ACE2) Receptor and Alzheimer’s disease
por: Lukiw, Walter J.
Publicado: (2021) -
Angiotensin-Converting Enzyme 2 Expression and Severity of SARS-CoV-2 Infection
por: Alabsi, Sarah, et al.
Publicado: (2023)